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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
















 A massive coronavirus 
testing campaign in 
Vietnam has found 
evidence that infected 
people who never show any 
symptoms can pass the 
virus to others. 
 Early in the global COVID-
19 outbreak, Vietnam 
began to repeatedly test 
people at high risk of 
infection. Those who tested 
positive were admitted to a 
hospital until they either 
recovered or tested 
negative. 
 Of roughly 14,000 people 
tested between mid-March 
and early April, 49 were 
infected. Le Van Tan at the 
Oxford University Clinical 
Research Unit in Ho Chi 
Minh City, Vietnam, and his 
colleagues monitored 30 of 
the 49 individuals and found 
that 13 developed no 
testing 
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 Article describes a 
murine model of 
broad and 
immediate utility to 
investigate COVID-
19 pathogenesis, 
























 Researchers have 
found a second 
protein that SARS-
CoV-2 uses to enter 
human cells, 
potentially offering a 
new target for 
vaccines and drugs. 
 The SARS-CoV-2 
protein called Spike 
is known to attach 
to a human protein 
called ACE2, which 
allows the virus to 





now found that the 
human protein 
neuropilin-1 (NRP1) 
also aids viral 
invasion. 
 Peter Cullen and 
Yohei Yamauchi at 
the University of 
Bristol, UK, and 
their colleagues 
showed that a 
fragment of the 
Spike protein can 
bind to NRP1 
05.06.20 Neuropilin-1 is 








 This team found 
that in mice, NRP1 
assists the entry of 
virus-sized particles 
into the central 
nervous system.  




the virus and NRP1 





Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article 
type 
Author(s) 
11.06.2020 Socio-demographic and 
epidemiological consideration of 
Africa’s COVID-19 response: what is 
the possible pandemic course? 
Nature Medicine | 
Comment 
Bamba Gaye et 
al. 
09.06.20 Update Alert: Epidemiology of and Risk 
Factors for Coronavirus Infection in 
Health Care Workers 
Annals of Internal 
Medicine | Letter 
Roger Chou, 
Tracy 




09.06.20 When the Dust Settles: Preventing a 
Mental Health Crisis in COVID-19 
Clinicians 
Annals of Internal 





09.06.20 The Impact of COVID-19 on Food 
Security and Nutrition             
UN | Policy Brief   
10.06.20 The Importance of Proper Death 
Certification During the COVID-19 
Pandemic 
JAMA | Viewpoint James R. Gill, 
Maura E. 
DeJoseph, DO 
10.06.20 Hydroxychloroquine side-effects raise 
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US NIH  Our World 
in Data: C19 
Testing 




Our World in 
Data 
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  US  COVID-19 
Primer 




     NIH 
LitCovid 
 UKCDR       
Information 
is Beautiful 
     WHO 
COVID-19 
Database 
        
LSHTM               
HealthMap 
(cases) 




              
  
6 
C19 Resource Hubs 







Health Topics   Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
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Development 
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Health 









Oxford Centre for 
Evidence-based 
Medicine 
    




 HEART     
UNESCO   NEJM  UKRI     
UN WFP   Oxford 
University 
Press 
 Evidence Aid     
GOARN   PLoS  NIH     
EPI-WIN   SAGE 
journals 
IFPRI Resources 
and Analyses of 
C19 Impact 
    
World Bank   Science  Prevent 
Epidemics  
    
Our World in 
Data 
  Springer 
Nature 




  SSRN 
(Preprints)  
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Online learning & events 









Online course 1 hour WHO 
16.06.2020 Africa beyond COVID-
19 
Virtual event 1h 30 
hours 
ODI 
15.06.2020 Poverty monitoring in 
the context of Covid-
19 




Nursing in Times of 
Crisis 
Online course 2 weeks – 
2 hours per 
week 
Johns Hopkins School 
of Nursing 
          
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 






















Webinar 1 hour WHO & ISQua – Dr 
Shams Syed, Dr Peter 
Lachman, Dr Teri 
Rynolds & Dr Ed Kelley 




5 hours Johns Hopkins 






5 sessions 1h 30 International Initiative 











online brief with Dr 
David Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 





























the Novel Coronavirus 
Online 
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of Edinburgh & Royal 
College of Physicians 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
